Cashu FinanceCashu Finance
  • Terminal
  • Pulse
  • Spotlight
  • News
  • Cashu Research
Log inSign Up
← Back to Terminal
  1. Stocks
  2. Basic Materials
  3. NYSE
  4. CSTM

Market Cap: $2.88B

CS

Constellium SE

CSTM
NYSE (New York Stock Exchange)USD
Invest in CSTM
OverviewNewsAnalyst ReportsFinancialsPolitician TradesInsider TradesExecutive
Cashu FinanceCashu Finance

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

StocksScreenersAboutAuthorsAdvertisersBrokersConferencesContact

Legal

Terms of ServicePrivacy PolicyEditorial PolicyCorrections Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Cashu Research is part of Cashu Technology Pty Ltd, which is an authorised representative (AR # 001318029) of Adviser Solutions Group Pty Ltd (ABN 88 601 875 521) (AFSL 485946) (ASG).

This material is general advice only and is not an offer for the purchase or sale of any financial product or service. The material is not intended to provide you with personal financial or tax advice and does not take into account your personal objectives, financial situation or needs. Although we believe that the material is correct, no warranty of accuracy, reliability or completeness is given, except for liability under statute which cannot be excluded. Please note that past performance may not be indicative of future performance and that no guarantee of performance, the return of capital or a particular rate of return is given by Cashu Technologies Pty Ltd, any of their related body corporates or any other person. To the maximum extent possible, Cashu Technologies Pty Ltd, their related body corporates or any other person do not accept any liability for any statement in this material.

Constellium SE Financials

Profitability, balance-sheet strength and valuation from the latest reported results (trailing twelve months).

Financial Health Scores

Piotroski F-Score

9/9 · Strong

Nine pass/fail checks on profitability, leverage, liquidity and efficiency. 7–9 is strong, 0–3 is weak.

Altman Z-Score

2.91
Distress <1.8Grey 1.8–3Safe >3

Grey zone: some financial stress. Worth monitoring.

From Revenue to Profit

How much of each dollar of sales is kept at each stage (last 12 months).

  • Revenue$10.05B100.0%
  • Gross Profit$1.31B13.1%
  • EBITDA$1.09B10.9%
  • Operating Profit (EBIT)$758M7.5%
  • Net Profit$574M5.7%

Balance Sheet Snapshot

Total assets of $5.86B, funded by:

Liabilities
$4.51B(77%)
Shareholders' equity
$1.34B
Debt / Equity
1.36x
Current Ratio
1.48x

Short-term assets just cover short-term liabilities.

Returns on Capital

How well management turns capital into profit. Above 10–15% is generally considered strong.

  • Return on Equity49.4%

    Profit generated per dollar of shareholders' money.

  • Return on Assets9.8%

    Profit generated per dollar of assets owned.

  • Return on Invested Capital13.0%

    Profit generated on debt and equity invested in the business.

  • Return on Capital Employed18.4%

    Operating profit per dollar of long-term capital.

Valuation at a Glance

Lower multiples can mean cheaper shares, or a market expecting weaker results.

Price / Earnings
5.06x

What investors pay for each dollar of yearly profit.

Price / Book
2.16x

Share price vs net assets per share. Under 1x = below book value.

Price / Sales
0.29x

Market cap vs yearly revenue.

EV / EBITDA
4.17x

Whole-business value (incl. debt) vs operating cash earnings.

Price / Free Cash Flow
8.96x

Market cap vs cash left after capital spending.

PEG Ratio
0.01x

P/E adjusted for earnings growth. Around 1x is often seen as fair.

All Key Metrics

Every trailing-twelve-month ratio behind the charts above, grouped by topic. Pick a category to browse.

Profitability

How much of each dollar of revenue turns into profit at each stage, over the last 12 months.

Gross Profit Margin
13.08%
EBITDA Margin
10.88%
EBIT Margin
7.54%
Pre-tax Margin
8.06%
Net Profit Margin
5.71%
Earnings Yield
19.78%

Valuation Multiples

How the share price compares with earnings, sales, book value and cash flow. Lower multiples can mean cheaper shares, or weaker prospects.

Price / Book
2.16
Price / Sales
0.29
Price / Earnings
5.06
PEG
0.01
Forward PEG
0.03
EV / Sales
0.45
EV / EBITDA
4.17
EV / Operating Cash Flow
7.11
EV / Free Cash Flow
14.16
Price / Free Cash Flow
8.96
Price / Operating Cash Flow
4.51

Cash Flow & Capital

How much cash the business generates, how much it reinvests, and what it returns to shareholders.

Free Cash Flow / Share
$2.38
Operating Cash Flow / Share
$4.75
Free Cash Flow Yield
11.11%
Capex / Revenue
3.18%
Capex / Operating Cash Flow
49.80%
Capex / Depreciation
0.95
Stock Compensation / Revenue
0.00%
Dividend Payout Ratio
0.00%
Dividend Yield
0.00%

Liquidity & Leverage

Whether the company can cover its short-term bills and how heavily it relies on debt.

Current Ratio
1.48
Quick Ratio
0.57
Cash Ratio
0.08
Debt / Assets
0.31
Debt / Capital
0.58
Debt / Equity
1.36
Long-Term Debt / Capital
0.57
Debt / Market Cap
63.08%
Net Debt / EBITDA
1.52
Solvency Ratio
0.20
Financial Leverage
4.39

Efficiency & Working Capital

How quickly the company turns assets, inventory and receivables into sales and cash.

Asset Turnover
1.72
Fixed Asset Turnover
4.08
Inventory Turnover
4.59
Receivables Turnover
10.02
Payables Turnover
5.87
Days Sales Outstanding
36.43
Days Inventory Outstanding
79.6
Days Payables Outstanding
62.14
Operating Cycle
116.03
Cash Conversion Cycle
53.9
Working Capital Turnover
10.07

Returns & Quality

How efficiently management turns shareholders' money and company assets into profit.

Return on Equity
49.37%
Return on Assets
9.80%
Return on Invested Capital
12.98%
ROCE
18.44%
Return on Tangible Assets
10.02%
Operating Return on Assets
11.62%
Income Quality
1.11
Tax Burden
0.71
Interest Burden
1.07

Balance Sheet & Intrinsic Metrics

What the company owns and owes, and asset-based value estimates per share.

Enterprise Value
$4.55B
Invested Capital
$3.6B
Working Capital
$1.01B
Tangible Asset Value
$1.22B
Net Current Asset Value
$-1.41B
Graham Number
$30.77
Graham Net-Net
-$19.66
Book Value / Share
$9.94
Tangible Book Value / Share
$9.01
Cash / Share
$1.17

Financial Health Scores

Composite scores and the latest reported totals behind them.

Piotroski Score
9
Altman Z-Score
2.91
Revenue
$10.05B
EBIT
$758M
Market Cap
$2.79B
Working Capital
$1.01B
Retained Earnings
$790M
Total Assets
$5.86B
Total Liabilities
$4.51B